Trial Profile
Healthy Heart Study: Can Insulin Glargine Improve Myocardial Function in Patients With Type 2 Diabetes and Coronary Artery Disease? A Prospective, Randomized, Controlled Clinical Study With Blinded Analysis of Ultrasound Data.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2011
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Metformin
- Indications Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 16 Sep 2011 Results presented at the 47th Annual Meeting of the European Association for the Study of Diabetes.
- 30 Dec 2009 New trial record